Toru Hifumi1, Akihiko Inoue2, Nobuaki Kokubu3, Mamoru Hase4, Naohiro Yonemoto5, Yasuhiro Kuroda6, Kenya Kawakita6, Hirotaka Sawano7, Yoshio Tahara8, Kenji Nishioka9, Shinichi Shirai10, Hiroshi Hazui11, Hideki Arimoto12, Kazunori Kashiwase13, Shunji Kasaoka14, Tomokazu Motomura15, Yuji Yasuga16, Hiroyuki Yokoyama17, Ken Nagao18, Hiroshi Nonogi19. 1. Department of Emergency and Critical Care Medicine, St. Luke's International Hospital, Japan; Emergency Medical Center, Kagawa University Hospital, Japan. Electronic address: hifumitoru@gmail.com. 2. Emergency Medical Center, Kagawa University Hospital, Japan; Department of Emergency and Critical Care Medicine, Hyogo Emergency Medical Center, Japan. 3. Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University, Japan. 4. Sapporo Teishinkai Hospital, Japan. 5. Department of Biostatistics, Kyoto University School of Public Health, Japan. 6. Emergency Medical Center, Kagawa University Hospital, Japan. 7. Senri Critical Care Medical Center, Saiseikai Senri Hospital, Japan. 8. Division of Cardiovascular Care Unit, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan. 9. Department of Cardiology, Hiroshima City Hospital, Japan. 10. Division of Cardiology, Kokura Memorial Hospital, Japan. 11. Emergency Medicine, Osaka Mishima Emergency and Critical Care Center, Japan. 12. Emergency and Critical Care Medical Center, Osaka City General Hospital, Japan. 13. Department of Internal Medicine, Division of Coronary Heart Disease, Hyogo College of Medicine, Japan. 14. Department of Emergency and General Medicine, Kumamoto University Hospital, Japan. 15. Shock & Trauma Center, Chiba Hokusoh Hospital, Nippon Medical School, Japan. 16. Department of Cardiology, Sumitomo hospital, Japan. 17. Yokoyama Medical Clinic, Japan. 18. Cardiovascular Center, Nihon University Hospital, Japan. 19. Shizuoka General Hospital, Japan.
Abstract
AIM: The European Resuscitation Council guidelines recommend a slow rate of rewarming of 0.25 °C/h-0.5 °C/h for out-of-hospital cardiac arrest (OHCA) patients receiving therapeutic hypothermia (TH). Conversely, a very slow rewarming of 1 °C/day is generally applied in Japan. The rewarming duration ranged from less than 24 h up to more than 50 h. No randomized control trials have examined the optimal rewarming speed for TH in OHCA patients. Therefore, we examined the association between the rewarming duration and neurological outcomes in OHCA patients who received TH. METHODS: This study was a secondary analysis of the Japanese Population-based Utstein-style study with defibrillation and basic/advanced Life Support Education and implementation-Hypothermia (J-PULSE-HYPO) study registry, a multicenter prospective cohort study. Patients suffering from OHCA who received TH (target temperature, 34 °C) after the return of spontaneous circulation from 2005 to 2011 in 14 hospitals throughout Japan were enrolled. The rewarming duration was defined as the time from the beginning of rewarming at a target temperature of 34 °C until reaching 36 °C. The primary outcome was an unfavorable neurological outcome at hospital discharge, i.e., a cerebral performance category of 3-5. RESULTS: The J-PULSE-HYPO study enrolled 452 OHCA patients. Of these, 328 were analyzed; 79.9% survived to hospital discharge, of which 56.4% had a favorable neurological outcome. Multivariable logistic regression analysis revealed that the rewarming duration was independently associated with unfavorable neurological outcomes [odds ratio (per 5 h), 0.89; 95% confidence interval, 0.79-0.99; p = 0.032]. CONCLUSION: A longer rewarming duration was significantly associated with and was an independent predictor of favorable neurological outcomes in OHCA patients who received TH.
AIM: The European Resuscitation Council guidelines recommend a slow rate of rewarming of 0.25 °C/h-0.5 °C/h for out-of-hospital cardiac arrest (OHCA) patients receiving therapeutic hypothermia (TH). Conversely, a very slow rewarming of 1 °C/day is generally applied in Japan. The rewarming duration ranged from less than 24 h up to more than 50 h. No randomized control trials have examined the optimal rewarming speed for TH in OHCA patients. Therefore, we examined the association between the rewarming duration and neurological outcomes in OHCA patients who received TH. METHODS: This study was a secondary analysis of the Japanese Population-based Utstein-style study with defibrillation and basic/advanced Life Support Education and implementation-Hypothermia (J-PULSE-HYPO) study registry, a multicenter prospective cohort study. Patients suffering from OHCA who received TH (target temperature, 34 °C) after the return of spontaneous circulation from 2005 to 2011 in 14 hospitals throughout Japan were enrolled. The rewarming duration was defined as the time from the beginning of rewarming at a target temperature of 34 °C until reaching 36 °C. The primary outcome was an unfavorable neurological outcome at hospital discharge, i.e., a cerebral performance category of 3-5. RESULTS: The J-PULSE-HYPO study enrolled 452 OHCA patients. Of these, 328 were analyzed; 79.9% survived to hospital discharge, of which 56.4% had a favorable neurological outcome. Multivariable logistic regression analysis revealed that the rewarming duration was independently associated with unfavorable neurological outcomes [odds ratio (per 5 h), 0.89; 95% confidence interval, 0.79-0.99; p = 0.032]. CONCLUSION: A longer rewarming duration was significantly associated with and was an independent predictor of favorable neurological outcomes in OHCA patients who received TH.
Authors: Anne Kirstine Hoeyer-Nielsen; Mathias J Holmberg; Erika F Christensen; Michael N Cocchi; Michael W Donnino; Anne V Grossestreuer Journal: Resuscitation Date: 2021-02-12 Impact factor: 5.262
Authors: Stefano G Daniele; Georg Trummer; Konstantin A Hossmann; Zvonimir Vrselja; Christoph Benk; Kevin T Gobeske; Domagoj Damjanovic; David Andrijevic; Jan-Steffen Pooth; David Dellal; Friedhelm Beyersdorf; Nenad Sestan Journal: Nat Rev Neurosci Date: 2021-07-21 Impact factor: 34.870